These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1999780)

  • 1. Cold water exposure and vaso-occlusive crises in sickle cell anemia.
    Resar LM; Oski FA
    J Pediatr; 1991 Mar; 118(3):407-9. PubMed ID: 1999780
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaso-occlusive pain crises in children with sickle cell anemia].
    Fournier-Charrière E
    Soins Pediatr Pueric; 2007 Feb; (234):21-6. PubMed ID: 17338413
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease.
    Amin MA; Amin AP; Kulkarni HR
    Ann Hematol; 2004 Jun; 83(6):331-5. PubMed ID: 15052371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trial prevention of vaso-occlusive crises in homozygote sickle cell anemia using piracetam].
    Sonnet J; Gini EK; Cornu G
    Ann Soc Belg Med Trop; 1985; 65(1):77-84. PubMed ID: 4004377
    [No Abstract]   [Full Text] [Related]  

  • 5. Differentiating vaso-occlusive crisis and infection in sickle cell anemia.
    Shah Y; Kumar A
    J Fam Pract; 1981 Oct; 13(5):752, 757. PubMed ID: 7276882
    [No Abstract]   [Full Text] [Related]  

  • 6. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
    Setty BN; Chen D; Stuart MJ
    Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of exertional death associated with sickle cell trait: can we make a parallel with vaso-occlusion mechanisms in sickle cell disease?
    Connes P; Harmon KG; Bergeron MF
    Br J Sports Med; 2013 Mar; 47(4):190. PubMed ID: 22611148
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronological incidence of vaso-occlusive crises in hemoglobinopathy S].
    González-Pérez JJ; Svarch E; Roque MC
    Sangre (Barc); 1986; 31(3):303-6. PubMed ID: 3750167
    [No Abstract]   [Full Text] [Related]  

  • 9. Sickle cell disease in India.
    Mohanty D; Mukherjee MB
    Curr Opin Hematol; 2002 Mar; 9(2):117-22. PubMed ID: 11844994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department.
    Lopez BL; Kreshak AA; Morris CR; Davis-Moon L; Ballas SK; Ma XL
    Br J Haematol; 2003 Feb; 120(3):532-4. PubMed ID: 12580975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of vaso-occlusive crisis of sickle-cell disease with pentoxifylline].
    Clerc M; Doh-Egueli D; Chapuis F; Durin A; Bertrand Y; Souillet G; Philippe N
    Pediatrie; 1989; 44(7):577-81. PubMed ID: 2812975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickling crises and altitude. Occurrence in the Colorado patient population.
    Mahony BS; Githens JH
    Clin Pediatr (Phila); 1979 Jul; 18(7):431-8. PubMed ID: 455876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report.
    Ahmed S; Siddiqui AK; Iqbal U; Sison CP; Shahid RK; Sheth M; Patel DV; Russo LA
    Eur J Haematol; 2004 Mar; 72(3):213-6. PubMed ID: 14962240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia.
    Bhatnagar P; Keefer JR; Casella JF; Barron-Casella EA; Bean CJ; Hooper CW; Payne AB; Arking DE; Debaun MR
    Pediatr Blood Cancer; 2013 Oct; 60(10):E125-7. PubMed ID: 23677903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A microfluidic computational fluid dynamics model for cellular interaction studies of sickle cell disease vaso-occlusions.
    Blakely IP; Horton RE
    Microvasc Res; 2020 Nov; 132():104052. PubMed ID: 32768462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in serum IL-10 levels is a surrogate marker for predicting vaso-occlusive crisis in sickle cell disease.
    Sarray S; Mahdi N; Saleh LR; Almaoui WY
    Am J Hematol; 2014 Jul; 89(7):789-90. PubMed ID: 24723483
    [No Abstract]   [Full Text] [Related]  

  • 18. Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan.
    Olabode JO; Shokunbi WA
    West Afr J Med; 2006; 25(4):284-8. PubMed ID: 17402517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is inhaled nitric oxide therapy more effective or safer than the conventional treatment for the treatment of vaso-occlusive crises in sickle-cell anemia?
    Moreira FT; de Oliveira CB; Gomez CM; Bernardo WM
    Rev Assoc Med Bras (1992); 2011; 57(3):253-4. PubMed ID: 21691684
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in intensity, location, and quality of vaso-occlusive pain in children with sickle cell disease.
    Jacob E; Miaskowski C; Savedra M; Beyer JE; Treadwell M; Styles L
    Pain; 2003 Mar; 102(1-2):187-93. PubMed ID: 12620610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.